Start in Medical Technology
Navigation Links
Start in Medical Technology
TriLink Launches CleanAmp(TM) dNTPs for Hot Start PCR
... acid-based compounds, has launched a new Hot start PCR reagent - CleanAmp(TM) dNTPs. ... offer a less expensive solution to improved hot start PCR results. Using CleanAmp(TM) dNTPs allows precise control at the start of PCR thermal cycling by blocking DNA polymerase ...Micromet Receives Milestone Payment for Filing of the First Clinical Trial Application for MT203
... obstructive pulmonary disease. "Since the start of our collaboration with Nycomed in 2007, we ... milestone and we are looking forward to the start of clinical trials with MT203." About ... statements regarding the expected timing of the start of clinical trials with MT203, and the potential ...Vantia Therapeutics' Pipeline Continues to Mature
... in H1 2009, with the Phase IIb study expected to start in the second half of the year. Up to 200 males ... data in H1 2009. Phase IIa trials are expected to start in the second half of this year, involving over ... asthma and COPD. Clinical trials are expected to start in 2010. The company has also initiated a new ...Scientists Discover Why Teeth Form in a Single Row
... Study Uncovers How Each Tooth Signals the Next to start Growing ROCHESTER, N.Y., Feb. 26 ... decreasing levels of inhibitory factors to start the BMP4-driven development of the next tooth. ... enough jaw has grown in for the next tooth to start forming atop it. The implications of the ...... study was the time from initial treatment to the start of unequivocal relief of the defining symptom. ... Dataset, the likelihood of a patient having the start of unequivocal relief of the defining symptom was ... group (p=0.048). The median time to the start of unequivocal relief of the defining symptom was ...
... Europe and North America (TG-MV-007 trial). The start of these pivotal clinical trials represents an ... "I am very pleased to announce the start of the Phase III trials of microplasmin for the ... the value of the Company's pipeline, and the start of these trials represent another important ...
... in development with Merck-Serono is expected to start a randomized, controlled, multicenter phase 2 ... in development with MedImmune, is expected to start an additional phase 2 clinical trial in patients ... and autoimmune diseases, is expected to start a first clinical phase 1 trial in mid 2009; ...
... (FCR) (375 mg/m^2 rituximab intravenously at the start of first cycle and 500 mg/m^2 on day 1 for all ... of future treatments. All blood cells start out as hematopoietic, or blood-forming, stem ... 1.67 represents endothelial dysfunction. At the start of the study, 18 patients had abnormal mean PAT ...
... survival time of 29.6 weeks (6.8 months) after start of AP 12009 treatment. One of these patients ... melanoma, survived more than 60 weeks after the start of AP 12009 treatment. Another patient with stage ... as of March 2008 148 weeks (34 months) after the start of treatment with AP 12009. After reaching the ...
Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease
... and Company (NYSE: LLY ) has announced today the start of a Phase III clinical trial studying LY450139, ... be blinded to the exact timing of this delayed start of study drug administration. "Alzheimer's is a ... medical need. Today, we are proud to announce the start of the IDENTITY clinical trial and hold hope that ...GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
... -- In July, GeoVax announced an early start of two new HIV/AIDS vaccine clinical (human) ... compliant trials were previously scheduled to start later in 2007 and are the 3rd and 4th in a four ... -- Excellent results led to authorization to start two new trials with GeoVax HIV/AIDS ...GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
... -- In July, GeoVax announced an early start of two new HIV/AIDS vaccine clinical (human) ... compliant trials were previously scheduled to start later in 2007 and are the 3rd and 4th in a four ... * Excellent results led to authorization to start two new trials with GeoVax HIV/AIDS ...... by sugammadex 16 mg/kg, 3 minutes after the start of rocuronium administration or received an ... to be followed by spontaneous recovery. From the start of neuromuscular blocking agent administration, ... group, time to recovery of T(1) to 90% from the start of sugammadex administration was 2.9 (1.7) ...
... Trials of novel anticancer agents. The mission of start is to accelerate the development of new ... clinical trials research. Research physicians at start have set unprecedented standards for the ... improved understanding and treatment of cancer. start is headquartered in San Antonio, Texas. For more ...
MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
... teplizumab dosing regimens administered at the start of the study and again at six months ... ages 8-35 with treatment at the start of the study and again at ... 8-30 with treatment at the start of the study and again at one ...Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
... SUSTENNA(TM) and similar medicines. Call your doctor right away if you start to develop twitching or jerking movements that you cannot control in your ... their risk for seizures. Call your doctor right away if you start thinking about suicide or wanting to hurt yourself. In a study of ...... (domestic) or 1-617-213-8835 (international) 10 minutes prior to the start time and use the passcode 13318888. A replay of the call will be ... . Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads ...
... is not for everyone . Certain patients with heart failure should not start taking ACTOS. ACTOS can cause new, or worsen, heart failure. Talk to ... doctor should perform a blood test to check for liver problems before you start ACTOS and periodically thereafter. Talk to your doctor immediately if you ...
Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
... (domestic) or 617-213-8899 (international) 10 minutes prior to the start time and use the passcode 40038100. A replay of the call will be ... . Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads ...... (domestic) or 617-213-8899 (international) 10 minutes prior to the start time and use the passcode 40038100. A replay of the call will be available ... . Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads ...
Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
... this year. John F. Crowley, President and CEO of Amicus stated, "The start of our Phase 3 trial with Amigal is a major milestone for Amicus and ... (ERT) or who have not received ERT for at least six months prior to the start of treatment with Amigal. The Amigal treatment arm dose and regimen will ...... histoplasmosis or coccidioidomycosis are common. You should not start SIMPONI(TM) if you have any kind of infection. Tell your doctor if you ... have been fatal. Your doctor may do blood tests before and after you start treatment with SIMPONI(TM). Tell your doctor if you know or think you may ...
... histoplasmosis or coccidioidomycosis are common. You should not start SIMPONI(TM) if you have any kind of infection. Tell your doctor if you ... have been fatal. Your doctor may do blood tests before and after you start treatment with SIMPONI(TM). Tell your doctor if you know or think you may ...
... tissue is located throughout the body, NHL and Hodgkin's disease can start almost anywhere(2,7,8). The most recent data indicate that more than ... lipids and hematological parameters should be evaluated prior to the start of therapy with Afinitor and periodically thereafter. Strong or moderate ...
EntreMed Presents Initial Clinical Results for ENMD-2076
... the program covers a spectrum of potential indications. The staggered start of the Phase 1 multiple myeloma and leukemia studies will allow us to start treatment at a higher dose, thereby reducing the number of dose ...Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
... (domestic) or 617-801-9715 (international) 10 minutes prior to the start time and use the passcode 29850656. A replay of the call will be ... . Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads ...AFFiRiS Begins Development of a Parkinson's Vaccine
... testing. AFFiRiS, based in Vienna, Austria, today announced the start of the pre-clinical development of its first Parkinson's vaccine PD01. The ... conclusion of this preclinical evaluation, initial clinical testing could start in 2010/11. The Parkinson's vaccine specifically targets the ...... a patient with progressive disease. Early death (within eight weeks from start of treatment) occurred in four patients (7 percent) in the DR group and ... endpoint of the study is objective response over a 24 week period from start of treatment as assessed according to the National Cancer Institute ...
... ACTOS is not for everyone. Certain patients with heart failure should not start taking ACTOS. ACTOS can cause or worsen congestive heart failure. Talk to ... doctor should perform a blood test to check for liver problems before you start ACTOS and periodically thereafter. Talk to your doctor immediately if you ...
AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA
... your doctor will monitor your liver function with a blood test before you start treatment with CASODEX, at regular intervals during the first 4 months of ... locally advanced prostate cancer. Treatment with the combination should start 8 weeks prior to starting and continue during radiation therapy. ZOLADEX ...... various molecular markers will also be studied. The trial is expected to start this fall and will be conducted at various sites in France. About Vion ... AML and high-risk myelodysplastic syndrome (MDS) patients is expected to start this fall. Triapine(R), a potent inhibitor of a key step in DNA synthesis, ...
... In fact, there is a correlation between the level of disability at the start of treatment and cognitive function 16 years later. More research is ... more comfortable, we continue to lead the way in helping people with MS start on and stay on treatment." About the Trials The 16-Year Long-term ...
Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351
... 2 study, in newly diagnosed, elderly patients with AML, is expected to start enrolling patients before the end of 2008. The second study, in AML patients who have relapsed following initial treatment, is projected to start enrolling patients in the first quarter of 2009. Interim Phase 1 data ...Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company
... department, are asking for it again when they require a subsequent IV start or blood draw following hospital admission. Our early market experience ... plans an additional clinical trial in total knee replacement surgeries to start in the fourth quarter of 2008. This trial is designed to enroll up to 240 ...Amicus Therapeutics Announces Second Quarter 2008 Financial Results
... the data from the completed Phase 2 clinical studies of Amigal support the start of Phase 3 development and agreed that Amigal meets the criteria to be ... participants are encouraged to go to the Web site 15 minutes prior to the start of the call to register, download and install any necessary software. ...Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy
... If your healthcare professional tells you that you can take ZIAGEN again, start taking it when you are around medical help or people who can call a doctor ... and you experience side effects, be sure to tell your doctor. When you start taking HIV medicines, your immune system may get stronger and could begin ...First Ever Study on Alzheimer's Disease Treatment in Hispanics Presented at Major Medical Meeting
... disease, and I encourage primary care physicians with Hispanic patients to start screening for signs of dementia at a younger age, potentially at 55 or 60 ... undiagnosed and untreated (approximately 40 percent). -- Hispanics start showing AD symptoms nearly seven years earlier than non-Hispanics. -- ...PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S.
... with our lead U.S. investigators, we have elected to postpone the start of the U.S. pivotal trial. We anticipate that this deferral will reduce ... of our RenalGuard study protocol so that we are well-positioned to start the trial with our targeted study sites. We remain very confident that ...... evidence of disease recurrence. Patients had no evidence of disease at the start of the trial as measured by imaging. Patients underwent restaging every ... be confined to those patients who had low dendritic cell count before the start of treatment. "We are encouraged about the potential of Leukine in ...
FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
... Companies confirm the start of TRILOGY ACS clinical trial to study Prasugrel against Clopidogrel in ... coronary intervention (PCI). Daiichi Sankyo and Lilly also confirm the start this month, as planned, of the TRILOGY ACS trial, a large Phase III ...Other ContentsselfselfselfselfselfselfselfselfselfconservativeconservativeconservativeconservativeconservativeconservativesemivalvesvalvesvalvesvalvesvalvesvalvesvesiclesvesiclesvesiclesvesiclesvesiclesseminalseminalseminalseminalseminaltubulestubulestubulestubulesOther Tagsconnectoractsactsactsactsacts
(Date:12/1/2009)...un attacks by sharks can be solved with a new tech...homp they put on their victims, according to a Uni... In a method analogous to analyzing human fingerp...isely comparing shark bites to the jaws and teeth ...rector of the International Shark Attack File, whi...
(Date:12/1/2009)...,abominable mystery, and it is a question which ha... did flowering plants evolve and how did they come... Ecology Letters reveals the evolutionary trigge...jor competitive advantage over rival species, lead...e study, by Dr Tim Brodribb and Dr Taylor Field o...
(Date:11/30/2009)...ew of the state of Antarctica,s climate and its re...ed this week (Tuesday 1 December) by the Scientifi...iew - Antarctic Climate Change and the Environment...ent, identifies areas for future scientific resear... makers have about Antarctic melting, sea-level ri...
Breaking Biology News(10 mins):New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3How did flowering plants evolve to dominate Earth? 2First comprehensive review of the state of Antarctica's climate 2Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 1Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 2Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 3Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 4Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 5Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 6New Jersey Surgery Centers Pick Health Informatics Consulting to Implement Patient Electronic Health Record Systems 13630 1New Jersey Surgery Centers Pick Health Informatics Consulting to Implement Patient Electronic Health Record Systems 13630 2Herb Shows Potential for Rheumatoid Arthritis 54847 1Herb Shows Potential for Rheumatoid Arthritis 54847 2Herb Shows Potential for Rheumatoid Arthritis 54847 3(Date:12/2/2009)...PRNewswire-FirstCall/ -- Gen-Probe Incorporated (N...er Jaffray Health Care Conference today at 2:30 p....be webcast live and may be accessed through a link...t www.gen-probe.com . The webcast will be availab...en-Probe ,, Gen-Probe Incorporated is a globa...
(Date:12/2/2009)...ewswire/ -- A randomized, controlled study compari...vasive treatment called percutaneous disc decompre...le both treatments help patients in the short run,...p to two years later. Results of the study, the fi...l meeting of the Radiological Society of North Ame...
(Date:12/2/2009)...2 LeapFrog Investments has announc... in AllLife, the innovative South African insurer ...nvestment brings together LeapFrog, the leading mi...Africa,s most innovative insurance businesses. The..., "AllLife has developed a distinctive and profit...
(Date:12/2/2009)...sound of suspicious areas of the breast, including...ernative to invasive biopsies for women under age ...nted today at the annual meeting of the Radiologic...ming high-quality breast ultrasound, we can reduce...agnostic procedures in young women," said senior a...
(Date:12/2/2009)...ale clinical trial presented today at the annual m...a (RSNA) provide the first strong evidence of the ...ith dense breasts who are at elevated risk for bre...MRI is highly sensitive in depicting early breast ...ltrasound in addition to mammography significantly...
Breaking Medicine News(10 mins):Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 3Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 3Health News:Targeted breast ultrasound can reduce biopsies for women under 40 2Health News:Annual screening with breast ultrasound or MRI could benefit some women 2[0] Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today[0] Outpatient Disc Treatment Gives Long-Term Back Pain Relief[0] LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer[0] Targeted breast ultrasound can reduce biopsies for women under 40[0] Annual screening with breast ultrasound or MRI could benefit some women
connectorfingertiptaskingknowscyborgstillbirthsverifiedpolyestercarriesmeningococciactsscrubbinghavenstrongly
Other Tagsempowerment 2serve 2serve 3serve 4serve 5serve 6serve 7serve 8serve 9serve 10spectrum 2spectrum 3spectrum 4spectrum 5spectrum 6spectrum 7critically 2critically 3critically 4island 2island 3island 4
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |